Table 3

Injection therapy for treatment of osteitis pubis

ArticleSubjectsAge (years)SportType of injectionNo of injectionsReturn to playFailures/complications
Holt10 M 2 FMean 20Football91% Lidocaine 1 mlChronic group: (16 weeks symptoms) eight athletes, mean 1.75 injectionsChronic group: seven out of eight athletes, mean 10 weeksChronic group: One athlete remained symptomatic after two injections and inguinal herniorrhaphy Acute group: none
Soccer20.25% Bupivacaine 1 mlAcute group: (7–10 days symptoms) three athletes, mean one injectionAcute group: three out of three athletes, all within 2 weeks
Ice hockey134 mg Dexamethasone 1 ml
Batt2 MMean 22Football13Betamethasone (strength/amount not specified)Mean 1.5 injectionsMean 10 weeksBoth athletes with/recurrent symptoms months later: Case 1: improved following prednisone taper and indomethacin Case 2: improved following prednisone taper and second corticosteroid injection
O'Connell14 M 2 FMean 28.4High-level athletes (not specified)0.5% Bupivacaine 1 ml Methylprednisolone 20 mgMean one injectionWithin 48 h: 14 out of 16 athletes with partial symptom improvement and resumed sportOne athlete required two additional injections of bupivacaine only over 6-month period. One athlete with/persistent pain referred for pubic symphysis fusion
At 2 weeks: 10 out of 16 noted continued pain relief
At 2 and 6 months: 5 out of 16 completely symptom free
Topol24 MMean 25Rugby11 Soccer13Prolotherapy of eight injection sites across pubic ramus, ischium and pubic symphysis with monthly injections of 12.5% dextrose, 0.5% lidocaineMean 2.8 injection sites11 athletes (1–2 injections): within 6 weeks 11 out of 13 athletes (>2 injections): within 3 monthsTwo non-responders unable to return to sport